Which has grown faster, RGEN or TXG?

Over the past five years, RGEN grew revenue faster — RGEN at a 9.08% CAGR versus TXG at 8.74%.

Is RGEN or TXG more profitable?

RGEN runs the higher net margin — RGEN at 5.29% versus TXG at -12.18%.

How have RGEN and TXG total returns compared?

Over the past 5 years, RGEN delivered -6.86% and TXG delivered -7.24% annualized total return. Past performance doesn't predict future results.

Repligen Corporation (RGEN) vs 10x Genomics, Inc. (TXG)

A side-by-side comparison of Repligen Corporation and 10x Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

RGEN

Repligen Corporation

$10.08B

$178.54HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT

TXG

10x Genomics, Inc.

$10.54B

$83.04HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT

Total return — RGEN vs TXG

growth of $100 · dividends reinvested · last 7y

RGEN +130.6% (+12.7%/yr)TXG +85.3% (+9.2%/yr)RGEN compounded faster over this window

RGEN TXG

RGEN vs TXG: by the numbers

•TXG is the larger company ($10.54B vs $10.08B market cap).
•RGEN is profitable (5.29% net margin) while TXG runs a net loss (-12.18%).
•RGEN grew revenue faster over the past five years (9.08% vs 8.74% CAGR).

Metrics side by side

Valuation

Metric	RGEN	TXG
P/E ratio	244.57	N/A
Forward P/E	86.70	N/A
P/S ratio	12.83	17.09
P/B ratio	4.77	12.77
EV / EBITDA	68.42	N/A
FCF yield	1.10%	1.15%

Profitability

Metric	RGEN	TXG
Gross margin	51.05%	70.03%
Operating margin	8.32%	-14.33%
Net margin	5.29%	-12.18%
ROE	1.97%	-9.10%
ROIC	1.85%	-9.57%

Growth (annualized)

Metric	RGEN	TXG
Revenue CAGR (5Y)	9.08%	8.74%
EPS CAGR (5Y)	-5.26%	N/A
FCF CAGR (5Y)	22.49%	N/A
Total return CAGR (5Y)	-6.86%	-7.24%

Frequently asked

Which has grown faster, RGEN or TXG?: Over the past five years, RGEN grew revenue faster — RGEN at a 9.08% CAGR versus TXG at 8.74%.
Is RGEN or TXG more profitable?: RGEN runs the higher net margin — RGEN at 5.29% versus TXG at -12.18%.
How have RGEN and TXG total returns compared?: Over the past 5 years, RGEN delivered -6.86% and TXG delivered -7.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full RGEN analysis Full TXG analysis Interactive comparison tool

Dig into the metrics

Repligen P/E ratio Repligen ROE 10x Genomics ROE Repligen operating margin 10x Genomics operating margin Repligen revenue growth 10x Genomics revenue growth Repligen free cash flow 10x Genomics free cash flow

Repligen & 10x Genomics appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.